To study the effect of single agent tablet Zinc(50mg), Xylocaine (10%) spray and tablet zinc (50mg) along with Xylocaine (10%) spray when given together in reducing the incidence of postoperative sore throat in patients undergoing General Anaesthesia.
Not Applicable
- Conditions
- Health Condition 1: O- Medical and SurgicalHealth Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2022/11/047405
- Lead Sponsor
- Dr Sivani Nanda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Age- 18 years to 60 years
2. ASA I to III
Exclusion Criteria
1.Refusal of patient to participate in study
2.ASA IV
3.Patients allergic to Zinc or Xylocaine
4.Patients with history of other form of allergies
5.Patients with history of Pharyngitis/Tonsillitis/Laryngitis/any pre-existing pharyngeal or laryngeal pathologies
6.Confirmed or suspected case of COVID 19
7.Smokers
8.Surgeries extending more than 3 hours
9.Surgeries done in prone position as Glyccopyrolate will be required
10.Patients with difficult airway
11.Surgeries requiring nasal intubation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of post operative sore throat at 4 hours of extubationTimepoint: 4 hours after extubation
- Secondary Outcome Measures
Name Time Method DysphagiaTimepoint: 4 hours after extubation;DysphoniaTimepoint: 4 hours after extubation;HoarsenessTimepoint: 4 hours after extubation;Nausea, VomitingTimepoint: 4 hours after extubation